These in vitro results are consistent with in vivo experimental and human clinical observations that have found autoantibodies against laminin, collagen IV (but not collagen I), B1AR, and CXAR as well as against myosin and actin in RHD and AM (39, 60–62, 78–85). This evidence concerns the gene ADRB1 and rheumatic heart disease.